Facundo Davaro
YOU?
Author Swipe
View article: Utilization of Partial Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma
Utilization of Partial Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma Open
Objectives: Cytoreductive nephrectomy for metastatic renal cell carcinoma (mRCC) is a standard of care. Partial nephrectomy (PN) in the setting of metastatic disease is an uncommon occurrence, and we aimed to characterize its utilization i…
View article: Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer
Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer Open
Objective To quantify the oncological risks of bladder‐sparing therapy (BST) in patients with Bacillus Calmette–Guérin (BCG)‐unresponsive non‐muscle‐invasive bladder cancer (NMIBC) compared to upfront radical cystectomy (RC). Patients and …
View article: Utilizing Cell-Free Urinary and Plasma Tumor DNA to Predict Pathologic Stage at Radical Cystectomy
Utilizing Cell-Free Urinary and Plasma Tumor DNA to Predict Pathologic Stage at Radical Cystectomy Open
ObjectiveTo assess the ability of cell-free urinary and plasma tumor DNA (cfDNA) to predict pathologic stage at radical cystectomy for patients with clinical muscle-invasive bladder cancer. MethodsA total of 25 patients with clinical muscl…
View article: Novel Use of ctDNA to Identify Muscle-Invasive and Non-Organ Confined Upper Tract Urothelial Carcinoma
Novel Use of ctDNA to Identify Muscle-Invasive and Non-Organ Confined Upper Tract Urothelial Carcinoma Open
PURPOSE Optimal patient selection for neoadjuvant chemotherapy prior to surgical extirpation is limited by the inaccuracy of contemporary clinical staging methods in high-risk upper tract urothelial carcinoma (UTUC). We investigated whethe…
View article: Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension Open
Introduction and Objective: Muscle invasive bladder cancer with extravesical extension is an aggressive disease entity that requires multimodal therapy. The benefits of adjuvant chemotherapy (AC) in patients with a positive soft-tissue sur…
View article: Increasing surgical wait time does not increase the risk of node positive prostate cancer: Implications for surgical planning during the COVID-19 pandemic and beyond
Increasing surgical wait time does not increase the risk of node positive prostate cancer: Implications for surgical planning during the COVID-19 pandemic and beyond Open
Purpose Prostate cancer (PCa) is a heterogeneous diagnosis, with a significant latency between diagnosis and risk of cancer specific mortality. During the COVID-19 pandemic, the need to balance the risk of COVID-19 exposure and resource al…
View article: Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals Open
View article: MP61-14 COMPARING TOTAL HOSPITAL CHARGES AND TOTAL COST FOR PATIENTS UNDERGOING PARTIAL OR RADIAL NEPHRECTOMY BY SURGICAL APPROACH
MP61-14 COMPARING TOTAL HOSPITAL CHARGES AND TOTAL COST FOR PATIENTS UNDERGOING PARTIAL OR RADIAL NEPHRECTOMY BY SURGICAL APPROACH Open
You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging/Surveillance III (MP61)1 Sep 2021MP61-14 COMPARING TOTAL HOSPITAL CHARGES AND TOTAL COST FOR PATIENTS UNDERGOING PARTIAL OR RADIAL NEPHRECTOMY BY SURGICAL AP…
View article: MP49-17 COMPARISON OF OPEN AND MINIMALLY INVASIVE APPROACH FOR NEPHRECTOMY WITH IVC THROMBECTOMY
MP49-17 COMPARISON OF OPEN AND MINIMALLY INVASIVE APPROACH FOR NEPHRECTOMY WITH IVC THROMBECTOMY Open
You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy IV (MP49)1 Sep 2021MP49-17 COMPARISON OF OPEN AND MINIMALLY INVASIVE APPROACH FOR NEPHRECTOMY WITH IVC THROMBECTOMY Dominic Barresi, Allison May, Facundo Davaro, L…
View article: Robot-assisted laparoscopic transperitoneal pyeloplasty case report
Robot-assisted laparoscopic transperitoneal pyeloplasty case report Open
Ureteropelvic junction obstruction (UPJO) can be caused by various anatomic abnormalities impairing drainage of urine from the kidney to the ureter. Patients often develop hydronephrosis and caliectasis which can lead to decreased function…
View article: Contemporary analysis of epididymal tumors using a national database
Contemporary analysis of epididymal tumors using a national database Open
Malignant epididymal tumors are exceedingly rare and typically present with localized disease. Surgical excision is associated with an estimated 85% CSS at 5-years.
View article: A Case of Heterotopic Ossification in Papillary Renal Cell Carcinoma Type 2
A Case of Heterotopic Ossification in Papillary Renal Cell Carcinoma Type 2 Open
Renal cell carcinoma (RCC) is associated with a variety of different histopathologic subtypes in which each subtype may be further subclassified. These entities carry with them unique prognoses and necessitate treatment with specific immun…
View article: MP64-06 DOES CHEMOTHERAPY CONFER A SURVIVAL BENEFIT FOR CLINICALLY NEURO-ENDOCRINE CARCINOMA OF THE PROSTATE: LESSONS LEARNT FROM THE REVIEW OF NATIONAL CANCER DATABASE
MP64-06 DOES CHEMOTHERAPY CONFER A SURVIVAL BENEFIT FOR CLINICALLY NEURO-ENDOCRINE CARCINOMA OF THE PROSTATE: LESSONS LEARNT FROM THE REVIEW OF NATIONAL CANCER DATABASE Open
You have accessJournal of UrologyProstate Cancer: Epidemiology & Natural History II (MP64)1 Apr 2020MP64-06 DOES CHEMOTHERAPY CONFER A SURVIVAL BENEFIT FOR CLINICALLY NEURO-ENDOCRINE CARCINOMA OF THE PROSTATE: LESSONS LEARNT FROM THE REVIE…
View article: MP76-06 A NATION-WIDE ANALYSIS OF PALLIATIVE CARE USE IN PATIENTS WITH METASTATIC PENILE CANCER
MP76-06 A NATION-WIDE ANALYSIS OF PALLIATIVE CARE USE IN PATIENTS WITH METASTATIC PENILE CANCER Open
You have accessJournal of UrologyPenile & Testicular Cancer: Penile & Testicular Cancer III (MP76)1 Apr 2020MP76-06 A NATION-WIDE ANALYSIS OF PALLIATIVE CARE USE IN PATIENTS WITH METASTATIC PENILE CANCER Facundo Davaro*, Allison May, Johar…
View article: Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer Open
Purpose: Previous studies have noted increased utilization of perioperative chemotherapy over time. The goal of this study was to determine trends in perioperative chemotherapy use within a contemporary population. Materials and Methods: T…
View article: Increased utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer
Increased utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer Open
View article: Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass
Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass Open
Background: Renal masses can be surgically treated by partial nephrectomy (PN) or radical nephrectomy (RN); however, in 2009 guidelines recommended PN as the standard of care for cT1a renal masses. Objective: To evaluate national trends of…
View article: MP72-08 NATIONAL TRENDS IN MANAGEMENT OF LOCALIZED HIGH RISK PROSTATE CANCER
MP72-08 NATIONAL TRENDS IN MANAGEMENT OF LOCALIZED HIGH RISK PROSTATE CANCER Open
You have accessJournal of UrologyProstate Cancer: Localized: Radiation Therapy (MP72)1 Apr 2019MP72-08 NATIONAL TRENDS IN MANAGEMENT OF LOCALIZED HIGH RISK PROSTATE CANCER Allison May*, Joshua Trierweiler, Anirudh Guduru, Johar Syed, Facun…
View article: MP37-01 CURRENT TRENDS AND DISPARITIES IN USE OF PARTIAL NEPHRECTOMY FOR T1A RENAL MASSES
MP37-01 CURRENT TRENDS AND DISPARITIES IN USE OF PARTIAL NEPHRECTOMY FOR T1A RENAL MASSES Open
You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy II (MP37)1 Apr 2019MP37-01 CURRENT TRENDS AND DISPARITIES IN USE OF PARTIAL NEPHRECTOMY FOR T1A RENAL MASSES Allison May*, Anirudh Guduru, Johar Syed, Facundo Dava…